PCA
NVO

PMV Capital Advisers’s Novo Nordisk NVO Stock Holding History

PMV Capital Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Sell
5,287
-14
-0.3% -$663 0.33% 27
2025
Q4 		$270K Hold
5,301
– – 0.49% 24
2025
Q3 		$294K Hold
5,301
– – 0.57% 23
2025
Q2 		$366K Hold
5,301
– – 0.82% 21
2025
Q1 		$368K Buy
5,301
+9
+0.2% +$743 0.89% 21
2024
Q4 		$455K Buy
+5,292
New +$572K 1.23% 14

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

PMV Capital Advisers's NVO Position: Q1 2026 in Review

PMV Capital Advisers reduced its Novo Nordisk (NVO) stake by 0.26% in Q1 2026, selling an estimated $663 and leaving 5,287 shares worth $194K. The position accounts for 0.33% of the portfolio, ranked #27.

PMV Capital Advisers first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $455K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • PMV Capital Advisers held 5,287 shares of Novo Nordisk worth $194K as of Q1 2026.
  • PMV Capital Advisers sold 14 Novo Nordisk shares in Q1 2026, an estimated $663.
  • Novo Nordisk made up 0.33% of PMV Capital Advisers's portfolio in Q1 2026, its #27 holding.
  • PMV Capital Advisers first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • PMV Capital Advisers's Novo Nordisk position peaked at $455K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on PMV Capital Advisers's 13F filing for Q1 2026, filed 16 Apr 2026.